Area Neuroscienze, UOC Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Area Diagnostica per Immagini, UOC Radiologia e Neuroradiologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Cerebrovasc Dis Extra. 2021;11(1):1-8. doi: 10.1159/000513025. Epub 2021 Jan 15.
We sought to verify the predicting role of a favorable profile on computed tomography perfusion (CTP) in the outcome of patients with acute ischemic stroke (AIS) due to large vessel occlusion (LVO) undergoing effective mechanical thrombectomy (MT).
We retrospectively enrolled 25 patients with AIS due to LVO and with a CTP study showing the presence of ischemic penumbra who underwent effective MT, regardless of the time of onset. The controls were 25 AIS patients with overlapping demographics and clinical and computed tomography angiography features at admission who had undergone successful MT within 6 h from onset and without a previous CTP study. The outcome measure was the modified Rankin Scale (mRS) score at 90 days.
Sixty-four percent of the study patients had an mRS score of 0-1 at 90 days versus 12% of the control patients (p < 0.001). Patients of the study group had a more favorable distribution of disability scores (median mRS [IQR] score of 0 [0-2] vs. 2 [2-3]). Multivariate analysis showed that the selection of patients based on a favorable CTP study was strongly associated (p < 0.001) with a better neurological outcome.
In our small-sized and retrospective study, the presence of ischemic penumbra was associated with a better clinical outcome in patients with AIS due to LVO after MT. In the future, a larger and controlled study with similar criteria of enrollment is needed to further validate the role of CTP in patient selection for MT, regardless of the time from the onset of symptoms.
我们旨在验证在接受有效机械取栓术(MT)的大血管闭塞(LVO)所致急性缺血性脑卒中(AIS)患者中,CTP 灌注(CTP)的有利特征对其预后的预测作用。
我们回顾性纳入 25 例 LVO 所致 AIS 患者,这些患者的 CTP 研究显示存在缺血半暗带,无论发病时间如何,均接受有效 MT。对照组为 25 例重叠人口统计学和临床及 CT 血管造影特征的 AIS 患者,他们在发病后 6 小时内成功接受 MT,且之前未行 CTP 研究。主要结局为 90 天时的改良 Rankin 量表(mRS)评分。
64%的研究患者在 90 天时的 mRS 评分为 0-1,而对照组患者为 12%(p<0.001)。研究组患者的残疾评分分布更有利(中位数 mRS [IQR]评分 0 [0-2] vs. 2 [2-3])。多变量分析显示,根据有利的 CTP 研究选择患者与更好的神经功能结局密切相关(p<0.001)。
在我们这项小规模、回顾性研究中,在接受 MT 治疗的 LVO 所致 AIS 患者中,存在缺血半暗带与更好的临床结局相关。未来,需要进行更大规模和更具对照性的研究,以进一步验证 CTP 在 MT 患者选择中的作用,无论症状发作后的时间如何。